Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of melatonin on sleep quality in IBD patients
IRCT20250205064653N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in inflammatory bowel disease (IBD), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Sleep quality. Started Mar 2025; status: completed.
02
Drugs
melatonin
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on IRCT20250205064653N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250205064653N1.